Artificial pancreas trumps pump therapy

A closed-loop insulin delivery system has been shown to be more effective than sensor-augmented pump therapy in the first real-world trial of the treatment in type 1 patients.

The three-month randomised crossover trial tested the “artificial beta cell” system in 33 adults day and night, and in 25 children and teens at night only.

The proportion of time the glucose level was in the target range was 11%